Active, Not Recruiting
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
NCT06564194
- Conditions
- Communicable Diseases, Disease Attributes, Infections, +4 more
- Locations
-
- Health Awareness Jupiter, Florida, United States
- DelRicht - New Orleans New Orleans, Louisiana, United States
- Sundance Clinical Research St Louis, Missouri, United States